AI
PRCT icon

Atom Investors’s Procept Biorobotics PRCT Stock Holding History

Atom Investors’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-15,807
Closed -$395K – 982
2026
Q1 		$395K Buy
15,807
+4,222
+36% +$119K 0.03% 512
2025
Q4 		$364K Sell
11,585
-11,171
-49% -$370K 0.03% 424
2025
Q3 		$812K Buy
+22,756
New +$1.04M 0.06% 279
2022
Q4 		– Sell
-12,686
Closed -$526K – 299
2022
Q3 		$526K Sell
12,686
-2,024
-14% -$80.7K 0.19% 148
2022
Q2 		$481K Buy
+14,710
New +$535K 0.21% 117

Other funds holding PRCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Atom Investors's PRCT Position: Q2 2026 in Review

Atom Investors sold out of Procept Biorobotics (PRCT) in Q2 2026, closing a stake of 15,807 shares — an estimated $395K sold.

Atom Investors first reported a position in PRCT in Q2 2022 and held it in 5 quarters. The position peaked at $812K in Q3 2025. 253 funds tracked by Wall St. Rank hold PRCT as of Q2 2026.

  • Atom Investors reported no remaining Procept Biorobotics position as of Q2 2026 after selling out during the quarter.
  • Atom Investors sold 15,807 Procept Biorobotics shares in Q2 2026, an estimated $395K.
  • Atom Investors first reported a position in Procept Biorobotics in Q2 2022 and held it in 5 quarters.
  • Atom Investors's Procept Biorobotics position peaked at $812K in Q3 2025.
  • 253 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2026.

Based on Atom Investors's 13F filing for Q2 2026, filed 14 Aug 2026.